Unichem, Macleods recall blood pressure, diabetes drugs from US market - (Business Standard via NewsPoints Desk)

  • Unichem Pharmaceuticals and Macleods Pharma are recalling various lots of tablets used for treatment of hypertension and diabetes from the US market, reported Business Standard.

  • Unichem is recalling 1.91 crore units of the hypertension drug clonidine hydrochloride from the US market, the report said.

  • The reason for the voluntary ongoing nationwide is "failed impurities/degredation specifications. This recall is initiated as a precautionary measure due to potential migration of benzophenone at very low level into product from container label," the FDA said.

  • Meanwhile, Macleods is recalling nearly 4700 bottles of pioglitazone and metformin, which are used to treat type 2 diabetes.

  • The reason for the voluntary nationwide ongoing recall is on account of it being "subpotent drug: out of specification assay result, below specification, for two lots of pioglitazone and metformin hydrochloride tablets," according to the FDA.

To read more NewsPoints articles, click here.